Jim Cramer's Lightning Round: Viking Therapeutics, Altria, Zoom, and ProFrac Holdings

Stock Analysis in the Lightning Round

• 💡 Jim Cramer begins the lightning round by discussing Viking Therapeutics, noting that while a bid was expected, he suggests focusing on Eli Lilly as a current winner.
• 🎯 Regarding Altria, Cramer acknowledges its historical strong returns and status as a dividend aristocrat, but states he cannot personally recommend tobacco stocks.
• ⚠️ For Zoom Communications, Cramer recognizes it as a good company with consistent cash flow but lacks a catalyst for a recommendation, leading him to pass on it.
• 🚫 In the case of ProFrac Holdings, Cramer expresses a strong negative stance on oil stocks currently, believing they are all headed lower and he does not want to touch them.